中华神经外科杂志
中華神經外科雜誌
중화신경외과잡지
Chinese Journal of Neurosurgery
2009年
9期
819-822
,共4页
兰川%吴南%李飞%陈志%朱刚%林江凯%高伯元%崔高宇%孟辉%冯华
蘭川%吳南%李飛%陳誌%硃剛%林江凱%高伯元%崔高宇%孟輝%馮華
란천%오남%리비%진지%주강%림강개%고백원%최고우%맹휘%풍화
血肿%脑肿瘤%显微外科手术
血腫%腦腫瘤%顯微外科手術
혈종%뇌종류%현미외과수술
Hematoma%Brain neoplasms%Microsurgery
目的 总结颅内肿瘤术后继发血肿的病例,探讨防治对策.方法 回顾性分析手术切除颅内肿瘤后继发血肿的临床资料.结果 702例颅内肿瘤病人术后19例(2.71%)继发颅内血肿;均发生于术后48 h内,16例发生于24 h内;12例病例出现脑疝或脑疝前期症状,7例为术后CT检查发现;继发血肿病例术中失血量平均为1102.63 ml;5例曾行脑室外引流;再次手术血肿清除后痊愈12例,部分神经功能障碍4例,植物生存1例,死亡2例.结论 术前、术中对患者危险因素的充分评估以及术后的密切监测是减少继发血肿的前提,治疗的关键在于早期发现、早期行血肿清除.
目的 總結顱內腫瘤術後繼髮血腫的病例,探討防治對策.方法 迴顧性分析手術切除顱內腫瘤後繼髮血腫的臨床資料.結果 702例顱內腫瘤病人術後19例(2.71%)繼髮顱內血腫;均髮生于術後48 h內,16例髮生于24 h內;12例病例齣現腦疝或腦疝前期癥狀,7例為術後CT檢查髮現;繼髮血腫病例術中失血量平均為1102.63 ml;5例曾行腦室外引流;再次手術血腫清除後痊愈12例,部分神經功能障礙4例,植物生存1例,死亡2例.結論 術前、術中對患者危險因素的充分評估以及術後的密切鑑測是減少繼髮血腫的前提,治療的關鍵在于早期髮現、早期行血腫清除.
목적 총결로내종류술후계발혈종적병례,탐토방치대책.방법 회고성분석수술절제로내종류후계발혈종적림상자료.결과 702례로내종류병인술후19례(2.71%)계발로내혈종;균발생우술후48 h내,16례발생우24 h내;12례병례출현뇌산혹뇌산전기증상,7례위술후CT검사발현;계발혈종병례술중실혈량평균위1102.63 ml;5례증행뇌실외인류;재차수술혈종청제후전유12례,부분신경공능장애4례,식물생존1례,사망2례.결론 술전、술중대환자위험인소적충분평고이급술후적밀절감측시감소계발혈종적전제,치료적관건재우조기발현、조기행혈종청제.
Objective To analyze the features and risk factors of secondary intracranial hematomas after microsurgery of intracranial tumors. Method The clinical records of the patients with secondary intracranial hematomas after brain tumor surgery were analyzed retrospectively. Results 19 out of 702 patients with brain tumor resection were suffered from secondary intracranial hematomas, all of which were found in 48 hours,and 16 were found in 24 hours. 12 cases with signs of heniation and others were found by regular CT scan. The patients had average blood loss of 1102.63 ml and external ventricular drainage were performed during surgery in 5 cases. Hematomas were eliminated in all of the 19 cases, and the outcomes of 12 patients were good, but there were also 4 cases with functional impairments, one in persistent vegetative state, and two death. Conclusions It is important for thoroughly evaluations of the risk factors to decrease the secondary intracranial hematomas, and the key points of the management for patients with secondary intracranial hematomas should be early detection and treatment.
